Publications
ICGEB publishes results from research undertaken in its laboratories in international, peer-reviewed scientific journals with high Impact Factor. The complete list of ICGEB publications and patents, from 1988 to April 2011 includes a total of over 2270 papers.
The total number of scientific publications authored, the total Impact Factor, average Impact Factor per year and per publication, as well as the average number of publications produced per year, per Group, per ICGEB-funded personnel, are all elements that are taken into consideration at the annual Council of Scientific Advisers' meetings, and Board of Governors' sessions, to gauge and monitor the scientific output of the ICGEB.
Recent publications of ICGEB Research Groups are linked to PubMed from the Research pages of each Group. The list of ICGEB's scientific publications can be downloaded here:
Patents
Patent and other intellectual property rights are assigned a key role in the achievement of the ICGEB's objectives. The Patent Policy remains that of promoting the development, production and wide applicatoin of biotechnology, particularly in the interest of developing countries. The ICGEB aims to overcome the difficulties encountered by developing countries in fostering innovation, ownership and in-house application, promotin the transfer of technology and know-how to Member countries.
ICGEB active patents and patent applications (58) to date:
|
Priority date |
Patent title |
Inventors |
| 23.12.2011 | microRNAs for cardiac regeneration throughinduction of cardiac myocyte proliferation. | Giacca, M., Zacchigna, S., Mano, M., Eulalio, A. |
| 04.11.2011 | A cellular model for the screening of tdp-43 aggregation affecting modules. | Baralle, F., Buratti, E., Budini, M. |
| 13.06.2011 | Pichia pastoris-expressed Dengue envelope-based virus like particles as safe, efficacious and inexpensive dengue subunit vaccines. | Mani, S., Tripathi, L., Kartik, D., Khanna, N., Swaminathan, S., Tyagi, P. |
| 01.06.2011 | Combinations of multiple molecular target inhibitors for treatment of abnormal cell growth. | Rao, K., Jailkhani, N., Ravichandran, S. |
| 14.03.2011 | Carbon-nanotube applications to modify electro-mechanical properties of cardiac myocytes. Joint application with University of Colorado and University of Trieste. | L. Mestroni, C. Long, J. Caldwell, L. Ballerini, M. Prato, G. Cellot, F.M. Toma, V. Martinelli, L. Zentilin |
| 01.03.2011 | Novel host factor as therapeutic targets for development of anti-tubercolosis. (Patent of addition to application 2089/DEL/2008) Joint application with Sphaera Pharma Pvt. Ltd. | Rao, K., Verma, D.K., Singh, V. |
| 01.03.2011 | Novel Composition for eliminating, reducing or retardinggrowth of drug resistant myco-bacteria. Joint application with Sphaera Pharma Pvt. Ltd. |
Rao, K., Verma, D.K., Singh, V. |
| 01.03.2011 | Novel Composition for treatment of multi drug resistant mycobacterial infection. Joint application with Sphaera Pharma Pvt. Ltd. | Rao, K., Verma, D.K., Singh, V. |
| 01.03.2011 | Novel Composition for tuberculosis. Joint application with Sphaera Pharma Pvt. Ltd. |
Rao, K., Verma, D.K., Singh, V. |
| 04.03.2011 | Artificial MicroRNA Mediated Geminivirus Resistance in Transgenic Plants. | Yadava, P., Mukerjee, S., Rajam, M. V. |
| 19.01.2011 | Immunotherapy of Infectious Diseases. | Das, G., Majumdar, T., Rao, K. |
| 25.11.2010 | Proteine ricombinanti con attivita’ di inattivazione selettiva di proteine bersaglio. | Burrone, O., Vecchi, L., Bestagno, M. |
| 15.10.2010 | Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente in gene, e loro uso in terapia genica. Joint application with University of Ferrara. |
Pagani, F., Pinotti, M. |
| 31.08.2010 | Plant Cell Wall Hydrolyzing Enzymes Insect Mid-Gut Bacterium. | Yazdani, S.S., Adlakha, N. |
| 02.08.2010 | Envelope domanin III based dengue vaccine candidate using HBsAg virus like particles as modular display system. | Khanna, N., Swaminathan, S., Dhar, N., Patil, A., Perween, G.C., Gurramkonda, G., Tyagi, P., Raut, R. |
| 08.06.2010 | De novo designed cationic amphipathic antibacterial peptides. | Chauhan, V.S., Pathak S., Gupta, M. |
| 08.06.2010 | Cancer combination therapy comprising multimolecular targeting. | Rao, K., Jailkhani, N., Ravichandran, S., Dugar S. |
| 10.05.2010 | Method for identification of functional modules and novel protein drug targets from biological networks. | Rao, K., Jailkhani, N., Ravichandran, S., Mande, S.C., Hegde, S.R. |
| 10.12.2009 | Peptides and their derivatives inhibiting extracellular reliase of HIV-1 TAT protein and HIV-1 replication. Joint applications with SNS. |
Giacca, M., Agostini, S. |
| 03.09.2009 | An anti-malarial vaccine. | Chitnis, C., Singh, S., Alam, M. |
| 29.06.2009 | Anticancer agent specific for brain tumors with mechanism of RECQ1 suppression. | Vindigni, A., Mendoza-Maldonado, R., Faoro, V., Odreman, F., Berti, M., Vindigni, M., Bonin, S., Skrap, M., Stanta, G. |
| 23.01.2009 | Anti dengue activity of Cissampelos pariera extracts. Joint application ICGEB - Ranbaxy Research Laboratory. |
Bhatnager, P.K., Katiyar, C.K., Khanna, N., Upadhyay, D.J., Swaminathan, S., Srinivas, K., Sharma, N., Kanaujia, A., Sood, R., Singhal, S., Shukla, G., Duggar, R., Pareek, P.K., Singh, Y., Khan, S., Raut, R. |
| 27.11.2008 | A method of expressing foreign proteins in plastids. | Reddy, V.S., Leelavathi, S., Bhardwaj, A. |
| 05.09.2008 | Pharmaceutical compositions containing calcium channel blockers for treatment of Tuberculosis. | Gupta, S., Singla, R., Behera, D., Khayyam, K.U., Korde, R., Malhotra, P., Natarajan K. |
| 04.09.2008 | Screening and identification of novel host factors as therapeutic targets for design and development of anti tuberculosis drugs and process thereof. | Rao, K.V.S., Jayaswal, S., Kamal, M.A., Kumar, D. |
| 01.09.2008 | Use of small peptides corresponding to protein-protein interface residues of Plasmodium falciparum ClpQ protease (PfClpQ) and ClpY ATPase (PfClpY) or small drug like molecules designed based upon these peptides that interface with interaction of PfClpQ and PfClpY, as anti-malarial drugs. | Rathore, S., Sinha, D., Chauhan, V.S., Gupta, D., Mohammed, A. |
| 06.08.2008 | Peptide from proregion of proteases inhibition of parasitic and infectious organisms. | Malhotra, P., Korde, R., Bhatnagar, R., Chauhan, V.S. |
| 04.08.2008 | Use of a novel plasmodium falciparum merozoite apical protein as malaria vaccine. | Mohammed, A., Chauhan, V.S. |
| 23.07.2008 | A fusion protein malaria vaccine consisting of Plasmodium falciparum merozoite surface protein 1 and plasmodium falciparum merozoite surface protein 3. | Mazumdar, S., Yazdani, S.S., Mohammed, A., Chauhan, V.S. |
| 23.07.2008 | A method for rapid and high frequency of regeneration of genetically transformed calli of Indica rice cultivar. | Singla-Pareek, S.L., Kumar, K., Sopory, S.K. |
| 23.07.2008 | Self Assembled hydrogel containing α, β- dehydrophenyalanine residue (PHE) and process for preparation thereof. | Panda, J.J., Mishra, A., Chauhan, V.S. |
| 30.01.2008 | Enzymatic composition of novel peptide(s) and protease(s) for degrading protease resistant proteins. | Bhatnagar, R., Gupta, R., Arora, N., Ramani, P. |
| 23.01.2008 | A humanized high affinity recombinant antibody against hepatitis B surface antigen. Joint application with All India Institute of Medical Sciences (AIIMS). |
Tiwari, A., Sinha, S., Khanna, N., Acharya, S.K. |
| 18.10.2007 | High frequency plant regeneration via somatic embryogenesis in Narasimha, an elite Indian cotton cultivar and a parental line used in hybrid seed production. | Reddy, V.S. |
| 12.06.2007 | A novel dengue envelope domain III - based tetravalent protein vaccine. | Khanna, N., Sathyamangalam, S. |
| 18.12.2006 | A recombinant mouse-human chimeric Fab against Hepatitis B surface antigen. Joint application with 1. Department of Biotechnology (DBT), 2. All India Institute of Medical Sciences (AIIMS). |
Sinha, S., Bose, B., Khanna, N., Acharya, S.K. |
| 01.11.2006 | Conformationally restricted alpha, beta-dehydrophenylalanine residue and its use in design of peptide nanotube. | Chauhan, V.S., Gupta, M., Mishra, A. |
| 25.05.2006 | Development of MY MIV based gene silencing vectors. | Mukherjee, S.K. |
| 20.09.2005 | Tetravalent Dengue specific domain III based chimeric recombinant protein as dengue diagnostic intermediated of high specificity for detenction of both dengue IgM. | Khanna, N., Swaminathan, S., Batra, G., Hapugoda, M. |
| 26.05.2005 | A pharmaceutical composition useful for the treatment of hepatocellular carcinoma. Joint application with CSIR. | Saxena, A.K., Gupta, B.D., Kapahi, B.K., Shanmugavel M., Mondhe, D.M., Qazi, G.N., Mathan, G., Kumar, V. |
| 25.05.2005 | De novo designated and synthesized cationic amphipathic peptides. | Sahal, D., Chetal, P., Ananthanaram, A., Chauhan, V.S. |
| 25.05.2005 | A Method of treating a plant to make it salt tolerant; a vector for use in the said treatment and its sequence thereof. | Bhattacharjee, B., Nair, S., Mohan, M., Vashisht, A.A., Tuteja, N. |
| 31.12.2004 | A novel selectable marker system for transgenic plants. | Singla-Pareek, S.L, Yadav, S.K., Reddy, M.K., Sopory, S.K. |
| 31.12.2004 | A new antifungal protein isolated from the seeds of chickpea, methods for isolation of such proteins, cloning of the encoding gene and transgenic plants incorporating such genes. | Reddy, V.S., Hassairi, A., Islam, A. |
| 26.08.2004 | Regeneration of plants and medium for use thereof. | Bhattacharjee, B., Nair, S., Mohan, M. |
| 19.04.2004 | Extration of latex of Calotropis procera and a process for the praparation thereof. Joint application with All India Institute of Medical Sciences (AIIMS). |
Kumar, V.L., Kumar, V. |
| 15.12.2003 | Biopesticeides for controlling inter alia sugarcane pests. Joint application with PDKV. |
Bhatnagar, R.K., Rajagopal, R., Rao, N.G.V. |
| 18.09.2003 | Overexpression of foreign genes in plants. | Reddy, V.S., Leelavathi, S., Nguyen, H.T. |
| 07.08.2003 | Novel recombinant dengue multiepitope (r-DME) proteins as diangostic intermediates. Joint application with DRDO. |
Khanna, N., Ananda Rao, R., Jana, A.M. |
| 16.04.2003 | Conscious evolution of proteins through codon huffling. | Ranganathan, A., Chopra, S. |
| 01.07.2002 | Method for screening a candidate substance as a potential drug for the treatment of malaria. | Sahal, D., Kannan, R., Chauhan, V.S. |
| 17.10.2001 | A method for preparing scar primers for use in marker assisted selection of rice varieties susceptible to attack by Gall Midge biotypes; method for preparing the same and method for screening rice varieties. | Mohan, M., Nair, S., Kumar, A., Sandesai, N. |
| 08.11.2001 | Process for the production of IFN Alfa of therapeutic level. | Tisminetzky, S., Baralle, F.E. |
| 02.08.2001 | Process for xykanase production. Joint application with IMTECH. |
Reddy, V.S., Leelavathi, S., Gupta, N., Maiti, S., Ghosh, A. |
| 03.08.1999 | Immunisation against Herpes Simplex virus. | Baralle, F.E., Fló, J., Tisminetzky,S. |
| 23.09.1998 | A bicistronic DNA construct comprising X-myc transgene for use in production of transgenic animal model systems for human hepatocellular carcinoma and transgenic animal model systems so produced. Joint application with NII. | Kumar, V., Singh, M., Totey, S.M., Anand, R.K |
| 22.09.1997 | Screening Method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53. | Matlashewski et al. |
| 11.09.1995 | Process for the preparation of very high purity gamma interferon. | Khanna N. |
Link to Biotechnology Transfer
For further information contact:
Mr. Decio Ripandelli
Director, Administration and External Relations
ICGEB, Padriciano 99, 34149 Trieste, Italy
Tel: +39-040-3757345, Fax: +39-040-3757363,
e-mail: decio@icgeb.org
